Evidence map›Paper›PMID 29038268›Full record

ArticleAntimicrobial agents and chemotherapy2018

Urinary Tract Conditions Affect Fosfomycin Activity against Escherichia coli Strains Harboring Chromosomal Mutations Involved in Fosfomycin Uptake.

G Martín-Gutiérrez, F Docobo-Pérez, J Rodriguez-Beltrán, J M Rodríguez-Martínez, J Aznar, A Pascual, J Blázquez

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Effects of pH on the Pathogenicity ofInternational journal of molecular sciences · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Fosfomycin Resistance Evolutionary Pathways ofInternational journal of molecular sciences · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

G Martín-GutiérrezUnidad de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen del Rocio, Seville, Spain.ORCID 0000-0002-3456-9532
F Docobo-PérezInstituto de Biomedicina de Sevilla (IBiS), Seville, Spain.
J Rodriguez-BeltránInstituto de Biomedicina de Sevilla (IBiS), Seville, Spain jeronimo.rodriguez.beltran@gmail.com blazquez@cnb.csic.es.ORCID 0000-0003-3014-1229
J M Rodríguez-MartínezInstituto de Biomedicina de Sevilla (IBiS), Seville, Spain.
J AznarUnidad de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen del Rocio, Seville, Spain.
A PascualInstituto de Biomedicina de Sevilla (IBiS), Seville, Spain.
J BlázquezUnidad de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen del Rocio, Seville, Spain jeronimo.rodriguez.beltran@gmail.com blazquez@cnb.csic.es.ORCID 0000-0003-0495-3848
Instituto de Biomedicina de Sevilla · ESInstituto de Salud Carlos III · ESConsejo Superior de Investigaciones Científicas · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The steps by which

Indexed as

Anti-Bacterial Agentsbeta-LactamasesChromosomes, BacterialEscherichia coliEscherichia coli InfectionsFosfomycinHumansMicrobial Sensitivity TestsMutationUrinary TractUrinary Tract InfectionsAnti-Bacterial Agentsbeta-LactamasesFosfomycinchromosomal mutationsEscherichia colifosfomycin activityfosfomycin resistanceurinary tract infectionUTI

Identifiers

PMID29038268
PMCPMC5740309
OpenAlexW2766747087

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.